Statin use and risk of COPD exacerbation requiring hospitalization

American Journal of Medicine

Volumn 126, Issue 7, 2013, Pages 598-606.e2

  Wang, Meng Ting ^a   Lo, Yu Wen ^a   Tsai, Cheng Liang ^b   Chang, Li Chien ^a   Malone, Daniel C ^c   Chu, Che Li ^a   Liou, Jun Ting ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Exacerbations; Nested case control study; Pharmacoepidemiology; Statins

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LONG ACTING BETA 2 AGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SHORT ACTING BETA 2 AGONIST; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BILLING AND CLAIMS; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DISEASE EXACERBATION; DISEASE SEVERITY; EMPLOYMENT; FEMALE; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SEX RATIO; TAIWAN; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84879163490     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.01.036     Document Type: Article

References (39)

1. World Health Organization. Chronic Obstructive Pulmonary Disease (COPD): burden of COPD. Available at http://www.who.int/mediacentre/factsheets/fs315/en/ . Accessed November 27, 2012.
2. D.M. Mannino, and A.S. Buist Global burden of COPD: risk factors, prevalence, and future trends Lancet 370 2007 765 773
3. A.D. Lopez, C.D. Mathers, and M. Ezzati Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 2006 1747 1757
4. W.C. Tan, P. Seale, and M. Ip Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific Respirology 14 2009 90 97
5. D.W. Brown, J.B. Croft, K.J. Greenlund, and W.H. Giles Trends in hospitalization with chronic obstructive pulmonary disease-United States, 1990-2005 COPD 7 2010 59 62
6. R.P. Young, R. Hopkins, and T.E. Eaton Pharmacological actions of statins: potential utility in COPD Eur Respir Rev 18 2009 222 232
7. J.R. Hurst, G. Hagan, and J.A. Wedzicha Mechanism of statin-associated mortality reduction in COPD Chest 132 2007 1409 author reply 1409-1410
8. K. Morimoto, W.J. Janssen, and M.B. Fessler Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease J Immunol 176 2006 7657 7665
9. S. Takahashi, H. Nakamura, and M. Seki Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice Am J Physiol Lung Cell Mol Physiol 294 2008 882 890
10. C. Arnaud, N.R. Veillard, and F. Mach Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis Curr Drug Targets Cardiovasc Haematol Disord 5 2005 127 134
11. T.M. Lee, M.S. Lin, and N.C. Chang Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin Am J Cardiol 101 2008 530 535
12. G.B. Mancini, M. Etminan, and B. Zhang Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease J Am Coll Cardiol 47 2006 2554 2560
13. C.C. Huang, W.L. Chan, and Y.C. Chen Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan Clin Ther 33 2011 1365 1370
14. K. Bartziokas, A.I. Papaioannou, and M. Minas Statins and outcome after hospitalization for COPD exacerbation: a prospective study Pulm Pharmacol Ther 24 2011 625 631
15. A.I. Blamoun, G.N. Batty, and V.A. DeBari Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study Int J Clin Pract 62 2008 1373 1378
16. E.M. Mortensen, L.A. Copeland, and M.J. Pugh Impact of statins and ACE inhibitors on mortality after COPD exacerbations Respir Res 10 2009 45 53
17. F.J. Frost, H. Petersen, K. Tollestrup, and B. Skipper Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins Chest 131 2007 1006 1012
18. V. Soyseth, P.H. Brekke, P. Smith, and T. Omland Statin use is associated with reduced mortality in COPD Eur Respir J 29 2007 279 283
19. S. Suissa Co-morbidity in COPD: the effects of cardiovascular drug therapies Respiration 80 2010 3 7
20. T.Y. Wu, A. Majeed, and K.N. Kuo An overview of the healthcare system in Taiwan Lond J Prim Care 3 2010 115 119
21. Taiwan National Health Insurance Research Database. Introduction to the National Health Insurance Research Database. Available at http://w3.nhri.org.tw/ nhird/date-01.html. Accessed November 27, 2012.
22. H.F. Chiu, S.C. Ho, and C.C. Chang Statins are associated with a reduced risk of gastric cancer: a population-based case-control study Am J Gastroenterol 106 2011 2098 2103
23. M.T. Wang, C.L. Tsai, and Y.W. Lo Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study Int J Cardiol 158 2012 279 284
24. C.A. Vaz Fragoso, J. Concato, and G. McAvay Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis Eur Respir J 40 2012 37 44
25. A. Gil, R. Gil, and I. Oyaguez Hospitalization by pneumonia and influenza in the 50-64 year old population in Spain (1999-2002) Hum Vaccin 2 2006 181 184
26. D. Lieberman, Y. Gelfer, and R. Varshavsky Pneumonic vs nonpneumonic acute exacerbations of COPD Chest 122 2002 1264 1270
27. World Health Organization Collaborating Centre for Drug Statistics Methodology ATC Index with DDDs and Guidelines for ATC Classification and DDD Assignment 2006 Norwegian Institute of Public Health Oslo, Norway
28. W.H. Shrank, A.R. Patrick, and M.A. Brookhart Healthy user and related biases in observational studies of preventive interventions: a primer for physicians J Gen Intern Med 26 2011 546 550
29. M.A. Brookhart, A.R. Patrick, and C. Dormuth Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect Am J Epidemiol 166 2007 348 354
30. S.F. Liu, K.C. Lin, and C.H. Chin Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease Respirology 12 2007 560 565
31. A. Nohria, A. Prsic, and P.Y. Liu Statins inhibit Rho kinase activity in patients with atherosclerosis Atherosclerosis 205 2009 517 521
32. P.M. Ridker, C.P. Cannon, and D. Morrow C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28
33. D. Shrikrishna, R. Astin, P.R. Kemp, and N.S. Hopkinson Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease Clin Sci (Lond) 123 2012 487 498
34. F.H. Rutten, N.P. Zuithoff, and E. Hak Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease Arch Intern Med 170 2010 880 887
35. D.E. Niewoehner, Y. Lokhnygina, and K. Rice Risk indexes for exacerbations and hospitalizations due to COPD Chest 131 2007 20 28
36. J. Garcia-Aymerich, I. Serra Pons, and D.M. Mannino Lung function impairment, COPD hospitalisations and subsequent mortality Thorax 66 2011 585 590
37. M.J. Hsieh, C.C. Lan, and N.H. Chen Effects of high-intensity exercise training in a pulmonary rehabilitation programme for patients with chronic obstructive pulmonary disease Respirology 12 2007 381 388
38. J.R. Hurst, J. Vestbo, and A. Anzueto Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 2010 1128 1138
39. C.F. Hsuan, T.L. Lee, and H.L. Chang A retrospective study of statin use and its effectiveness in Taiwanese Acta Cardiol Sin 25 2009 18 25